Cell Line Development: Identifying Stable Biologic Candidates
Cell line development (CLD) is a critical aspect of the drug discovery process, and nowhere is this more apparent than…
Read MoreCharacterization of Protein Aggregates and Extrinsic Particles from Cell Line Development Through Release
Aura PTx is a complete protein therapeutic stability solution that enables characterization of subvisible particle aggregates from developability assessment through…
Read MoreCharacterize and Identify Subvisible Protein and Polysorbate Aggregates in Protein Therapeutics
Polysorbates 20 and 80 are excipients used in >70% of marketed parenteral biological drugs to improve product stability and shelf…
Read MoreEnsuring Safety to Achieve Rapid Release with Aura
Presented in-person at the 3rd annual Cell Therapy Analytical Development Summit in Boston, MA, CSO and co-founder Bernardo Cordovez, Ph.D.…
Read MoreFinding the Needle in a Haystack: Rapid Assays to Detect Degraded Polysorbate and Other Problems Lurking in your Formulation
Polysorbates 20 and 80 are excipients used in >70% of marketed parenteral biological drugs to improve product stability and shelf…
Read MoreFrom Cell Line to Final Formulation: Characterizing mAb Stability Throughout the Development Pathway
Antibody-producing Chinese hamster ovary (CHO) cell lines have been long used to produce antibodies without aggregation in mind. Aura+® is…
Read MoreApp Note 2: Accurate Subvisible Particle Analysis With 10x Less Sample
Please fill out the form to download the app note.
Read MoreApp Note 3: A New Method for Measuring Particulates in Protein Drug Formulations with Complex Excipients
Please fill out the form to download the app note.
Read MoreApp Note 4: Sized Right For Particle Analysis
Please fill out the form to download the app note.
Read MoreApp Note 7: Protein Aggregate Identification with FMM: Rapidly Distinguish Protein from Non-Protein Particles in Biologic Formulations
Please fill out the form to download the app note.
Read More